Analytical Data
-
基因名
FILIP1
- Application
-
别名
FILIP1；KIAA1275；Filamin-A-interacting Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7Z7B0
-
表达区间
71-260aa
-
氨基酸序列
KSLELSKEDLIQLLSIMEGELQAREDVIHMLKTEKTKPEVLEAHYGSAEPEKVLRVLHRDAILAQEKSIGEDVYEKPISELDRLEEKQKETYRRMLEQLLLAEKCHRRTVYELENEKHKHTDYMNKSDDFTNLLEQERERLKKLLEQEKAYQARKEKENAKRLNKLRDELVKLKSFALMLVDERQMHIEQ
-
分子量
30.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FILIP1 (Filamin A Interacting Protein 1) is a relatively novel protein that has garnered attention in the field of cell biology due to its potential roles in cytoskeletal dynamics and cellular signaling. It is known to interact with filamin A, an important actin-binding protein that contributes to the organization of the cytoskeleton and cellular architecture. Previous studies have suggested that FILIP1 may play a critical role in regulating cell adhesion, migration, and mechanotransduction, processes that are essential for various physiological functions and developmental processes. Additionally, dysregulation of FILIP1 expression has been implicated in several diseases, including cancer, where it may influence tumor progression and metastasis. Researchers are keen to explore the functional mechanisms of FILIP1 as well as its interactions with filamin A and other cytoskeletal components. Understanding these pathways may uncover novel therapeutic targets for diseases characterized by cytoskeletal abnormalities and inform strategies to modulate cellular behaviors in both health and disease. As such, FILIP1 represents a promising avenue for further investigation in the realms of cell motility, tissue engineering, and potential clinical applications.
